John Flavin, Portal Innovations CEO, joins 'Fast Money' to talk what we can expect to see from the J.P. Morgan Healthcare ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

About ADARx Pharmaceuticals ADARx Pharmaceuticals, Inc. is a late-stage clinical biotechnology company dedicated to transforming cutting-edge science into next-generation RNA medicines across a wide ...

Reports preliminary fourth quarter 2024 revenue in the range of approximately $19.2 million to $19.4 million Reports preliminary full-year 2024 revenue in the range of approximately $73.1 million to ...

A choppy stock market challenges investors to be patient and choose stocks carefully as the Q4 earnings season gets underway.

As expected for a growth strategy, most of the assets tend to be invested in the technology, healthcare ... the vast majority of her 20 years at J.P. Morgan on this team as an analyst and then ...

Tony Lee joined the value team in 2018; he covers healthcare, insurance ... who average 22 years of industry experience. J.P. Morgan is a well-resourced, diligent, and responsible steward of ...